JID innovations : skin science from molecules to population health

JID Innov · ISSN (e) 2667-0267 · 3 papers in corpus
2026
Topical Salbutamol Cutaneous Gel Is Safe in a Double-Blind, Placebo-Controlled, Randomized Trial of Scarring from Sutured Wound Margins on the Arms of Healthy Human Volunteers.
doi:10.1016/j.xjidi.2025.100426 ·PMID:41541550

Salbutamol is a well-established β2-adrenergic receptor agonist used clinically for the reversal of bronchospasm. A functional β2-adrenergic receptor agonist network exists in the skin, which can alter skin cell migration and proliferation,…

other 2022
Atopic Dermatitis Is Associated with Preeclampsia and Endometriosis
doi:10.1016/j.xjidi.2022.100123 ·PMID:35620705
2022
Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-Staphylococcus Bacteria.
doi:10.1016/j.xjidi.2022.100132 ·PMID:36161104

The nasal microbiome of patients with cutaneous T-cell lymphoma (CTCL) remains unexplored despite growing evidence connecting nasal bacteria to skin health and disease. Nasal swabs from 45 patients with CTCL (40 with mycosis fungoides, 5 wi…